| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.9B | $25.9B | $25.5B | $23.2B | $23.2B | $19.2B | $5.3B | $5.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.0B | $2.9B | — | — | — | — | $2.2B | $2.2B |
| Operating Income | $12.4B | $11.7B | $11.6B | $9.4B | $10.4B | $7.3B | $2.3B | $2.0B |
| Net Income | $8.6B | $8.2B | $8.5B | $6.2B | $7.5B | $4.7B | $1.6B | $1.4B |
| EPS (Basic) | $12.00 | $11.45 | $11.63 | $8.39 | $10.11 | $6.35 | $2.10 | $1.84 |
| EPS (Diluted) | $11.95 | $11.39 | $11.56 | $8.33 | $10.04 | $6.31 | $2.08 | $1.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $59.5B | $55.2B | $56.1B | $50.4B | $53.9B | $52.6B | $47.5B | $32.8B |
| Current Assets | $4.2B | $4.6B | $8.0B | $5.4B | $7.1B | $6.2B | $3.6B | $4.1B |
| Cash & Equivalents | $0.8B | $1.1B | $4.6B | $2.6B | $4.7B | $3.4B | $0.9B | $0.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.4B | $3.9B | $6.9B | $3.8B | $4.0B | $6.2B | $3.6B | $3.0B |
| Stockholders' Equity | $-1.8B | $-3.8B | $-4.7B | $-6.0B | $-4.6B | $-7.8B | $-8.2B | $-6.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.6B | $9.4B | $9.6B | $7.4B | $9.1B | $6.3B | $8.1B | $7.0B |
| Investing Cash Flow | $-3.8B | $-5.3B | $-3.2B | $-2.7B | $-2.2B | $-1.5B | $-3.1B | $-2.5B |
| Capital Expenditures | $3.4B | $2.8B | $2.4B | $1.9B | $2.0B | $1.6B | $2.4B | $2.7B |
| Financing Cash Flow | $-7.1B | $-7.5B | $-4.4B | $-6.6B | $-5.6B | $-2.2B | $-5.0B | $-5.9B |